Finally, our findings in established and patient-derived breast cancer cells led us to analyze the correlation between aberrant expression of NOTCH3 and the overall survival of patients with claudin-low breast tumors using copy number aberrations, somatic mutations, and gene expression data derived from the METABRIC study [30]. The gene discussed is NOTCH3; the disease is breast carcinoma.